Secukinumab Efficacy on Psoriatic Arthritis GRAPPA-OMERACT Core Domains in Patients with or Without Prior Tumor Necrosis Factor Inhibitor Use: Pooled Analysis of Four Phase 3 Studies

BACKGROUND: Psoriatic arthritis (PsA) is a chronic, heterogeneous, immune-mediated disease manifesting as a spectrum of possible inflammatory signs and symptoms. Clinicians need therapeutic choices that work across all active PsA disease domains, as well as practical information about efficacy of av...

Descripción completa

Detalles Bibliográficos
Autores principales: Orbai, Ana-Maria, Husni, M. Elaine, Gladman, Dafna D., Leung, Ying Ying, Siebert, Stefan, Tillett, William, Vis, Marijn, Chambenoit, Olivier, Meng, Xiangyi, Mease, Philip J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Healthcare 2021
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8380608/
https://www.ncbi.nlm.nih.gov/pubmed/34218429
http://dx.doi.org/10.1007/s40744-021-00337-5

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8380608/
https://www.ncbi.nlm.nih.gov/pubmed/34218429
http://dx.doi.org/10.1007/s40744-021-00337-5

Ejemplares similares